drugset / Trial / NCT03452189

The Effect of an Antibiotic on the Production of Uremic Toxins by the Gut Microbiome

NCT03452189

Phase 2 Completed 15 enrolled NYU Langone Health
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine if multiple doses of vancomycin over the course of 3 months will perturb the intestinal flora (microbiome) and result in reduced serum concentration of the uremic toxin indoxyl sulfate and p-cresyl sulfate. The design of the study will permit investigators to assess the variability of serum uremic retention solute concentrations with and without antibiotic over a three-month period.

Timeline

Start
2017-11-27
Primary completion
2018-08-18
Completion
2018-08-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vancomycin Other / unclassified 250 mg Oral